{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:15:30Z","timestamp":1792700130808,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.esmogo.2025.100276","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:24:46Z","timestamp":1765826686000},"page":"100276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study"],"prefix":"10.1016","volume":"11","author":[{"given":"P.","family":"Andena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8044-4207","authenticated-orcid":false,"given":"F.","family":"Nichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bartalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ljevar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2840-9751","authenticated-orcid":false,"given":"A.","family":"Michelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Prisciandaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Franza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5388-7414","authenticated-orcid":false,"given":"G.","family":"Grelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ziranu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Coppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sciortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zapelloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-0333","authenticated-orcid":false,"given":"S.K.","family":"Garattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vivaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Scartozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"de Braud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pietrantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmogo.2025.100276_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/OP.22.00328","article-title":"Pancreatic adenocarcinoma management","volume":"19","author":"Jiang","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"10039","key":"10.1016\/j.esmogo.2025.100276_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100276_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50756","article-title":"NALIRIFOX, FOLFIRINOX, and gemcitabine with nab-paclitaxel as first-line chemotherapy for metastatic pancreatic cancer: a systematic review and meta-analysis","volume":"7","author":"Nichetti","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"13","key":"10.1016\/j.esmogo.2025.100276_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.19.02931","article-title":"Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA\/PALB2 mutation","volume":"38","author":"O'Reilly","year":"2020","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.esmogo.2025.100276_bib5","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","article-title":"Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection","volume":"26","author":"Park","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"14","key":"10.1016\/j.esmogo.2025.100276_bib6","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-22-3116","article-title":"Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer","volume":"29","author":"Cortellini","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"22","key":"10.1016\/j.esmogo.2025.100276_bib7","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.3390\/cancers13225735","article-title":"Diabetes and cancer: risk, challenges, management and outcomes","volume":"13","author":"Shahid","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100276_bib8","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/1078-0432.CCR-20-4928","article-title":"Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET)","volume":"27","author":"Vernieri","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100276_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","article-title":"Employing metabolism to improve the diagnosis and treatment of pancreatic cancer","volume":"31","author":"Halbrook","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100276_bib10","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/jnci\/djae070","article-title":"Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study","volume":"116","author":"van Eijck","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100276_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/cancers15020498","article-title":"Biological and clinical impacts of glucose metabolism in pancreatic ductal adenocarcinoma","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100276_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/bjc.2016.277","article-title":"The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer","volume":"115","author":"Kleeff","year":"2016","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100276_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00592-019-01337-2","article-title":"The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis","volume":"56","author":"Ma","year":"2019","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100276_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0300891620976945","article-title":"Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus","volume":"107","author":"Pretta","year":"2021","journal-title":"Tumori"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100276_bib15","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1038\/s41467-023-38921-8","article-title":"Increased glucose availability sensitizes pancreatic cancer to chemotherapy","volume":"14","author":"Vaziri-Gohar","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100276_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"suppl 1","key":"10.1016\/j.esmogo.2025.100276_bib17","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"7884","key":"10.1016\/j.esmogo.2025.100276_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41586-021-04049-2","article-title":"Low glycaemic diets alter lipid metabolism to influence tumour growth","volume":"599","author":"Lien","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100276_bib19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s43018-022-00393-y","article-title":"Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors","volume":"3","author":"Vaziri-Gohar","year":"2022","journal-title":"Nat Cancer"},{"issue":"31","key":"10.1016\/j.esmogo.2025.100276_bib20","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1200\/JCO.23.02659","article-title":"Devimistat (CPI-613) with modified fluorouarcil, oxaliplatin, irinotecan, and leucovorin (FFX) versus FFX for patients with metastatic adenocarcinoma of the pancreas: the phase III AVENGER 500 study","volume":"42","author":"Philip","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmogo.2025.100276_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejca.2022.05.046","article-title":"Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: a sub-analysis of the NCT03340935 trial","volume":"172","author":"Ligorio","year":"2022","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100276_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/2159-8290.CD-21-0030","article-title":"Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer","volume":"12","author":"Vernieri","year":"2022","journal-title":"Cancer Discov"},{"issue":"suppl 4","key":"10.1016\/j.esmogo.2025.100276_bib23","article-title":"Randomized phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancer","volume":"40","author":"Hanna","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100276_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","article-title":"Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer","volume":"178","author":"Ligorio","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100276_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","article-title":"Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein","volume":"75","author":"Kamphorst","year":"2015","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100276_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s42255-022-00583-z","article-title":"Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia","volume":"4","author":"Garcia-Bermudez","year":"2022","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100276_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/1078-0432.CCR-19-1543","article-title":"Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer","volume":"26","author":"Karasinska","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100276_bib28","article-title":"Metabolic classification suggests the GLUT1\/ALDOB\/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer","volume":"4","author":"Li","year":"2023","journal-title":"Cell Rep Med"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100276_bib29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/2159-8290.CD-24-0027","article-title":"Translational and therapeutic evaluation of RAS-GTP inhibition by RMC-6236 in RAS-driven cancers","volume":"14","author":"Jiang","year":"2024","journal-title":"Cancer Discov"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825001451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825001451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:06:14Z","timestamp":1775315174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819825001451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S2949819825001451"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100276","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100276"}}